Catalyst Pharmaceuticals, Inc. (CPRX)
 NASDAQ: CPRX · Real-Time Price · USD
 20.97
 -0.04 (-0.19%)
  At close: Oct 30, 2025, 4:00 PM EDT
20.85
 -0.12 (-0.57%)
  After-hours: Oct 30, 2025, 7:13 PM EDT
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees 
 181
Change (1Y) 
 14
Growth (1Y) 
 8.38%
Revenue / Employee 
 $3,085,630
Profits / Employee 
 $1,152,845
Market Cap 
2.57B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 181 | 14 | 8.38% | 
| Dec 31, 2023 | 167 | 85 | 103.66% | 
| Dec 31, 2022 | 82 | 6 | 7.89% | 
| Dec 31, 2021 | 76 | 2 | 2.70% | 
| Dec 31, 2020 | 74 | -2 | -2.63% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
CPRX News
- 8 days ago - Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 21 days ago - Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences - GlobeNewsWire
- 4 weeks ago - Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals - GlobeNewsWire
- 3 months ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update - GlobeNewsWire